BROWSE·page 101 of 1397

Browse EX-10 agreements

16,757 total material contract exhibits.


EX-10.23

Talawar Tx Inc.

Susannah Gray

[Email]

9/15/2026

Dear Susannah:

We are very pleased to invite you to join the board of directors (the “Board”) of Talawar Tx Inc. (the “Company”) as a director, which appointment shall occur after the Company has obtained the requisite corporate approvals. It is anticipated that your appointment will be effective October 1, 2026. In addition, in connection with the Company’s pending business combination with JATT II Acquisition Corp (the “Business Combination”), the Board expects to form an audit committee of the Board (the “Audit Committee”) and, subject to requisite corporate approvals, is expected to appoint you as Chair of the Audit Committee.

…

EX-10.23·S-4/A·CIK 2140859·ACC 0001193125-26-413188·Filed Oct 05, 2026, 08:13 ET

EX-10.22

Talawar Tx Inc.

TALAWAR TX INC.

May 29, 2026

Praveen Tipirneni

[Email]

Dear Praveen:

We are very pleased to invite you to join the board of directors (the “Board”) of Talawar Tx Inc. (the “Company”) as a director.

Following your appointment to the Board, which shall occur after the Company has obtained the requisite corporate approvals for such appointment, you will be eligible to receive equity awards in the Company under the terms of the Company’s 2026 Equity Incentive Plan (the “2026 Plan”).

…

EX-10.22·S-4/A·CIK 2140859·ACC 0001193125-26-413188·Filed Oct 05, 2026, 08:13 ET

EX-10.1

FLEX LTD.

**Certain confidential information contained in this document, marked by [****], has been omitted because it is both (i) not material and (ii) the type that the Company treats as private or confidential. **

**EXECUTION VERSION **

**Axiom Solutions International, Inc. **

**Series A Convertible Preferred Stock Investment Agreement **

Dated as of October 2, 2026


**TABLE OF CONTENTS **

Page

…

EX-10.1·8-K·CIK 866374·ACC 0001193125-26-413173·Filed Oct 05, 2026, 08:07 ET

Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Triple asterisks denote omissions.

THIRD AMENDMENT AND LIMITED WAIVER TO CREDIT AGREEMENT

This THIRD AMENDMENT AND LIMITED WAIVER TO CREDIT AGREEMENT, dated as of September 30, 2026 (this “Amendment”), is entered into by and among FTC Solar, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties party hereto, Acquiom Agency Services LLC, as administrative agent (in such capacity, including any successor thereto, the “Administrative Agent”) for itself and, pursuant to the limited power of attorney set forth in the Lender Direction Letter (as defined below), as attorney-in-fact for each Directing Lender (as defined below) party hereto, the Lenders party hereto and (solely for purposes of Section 5) the Subordinated Creditor (as defined below).

…

EX-10.1·8-K·CIK 1828161·ACC 0001213900-26-106656·Filed Oct 05, 2026, 08:05 ET

**CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. CERTAIN SCHEDULES AND ANNEXES HAVE BEEN OMITTED PURSUANT TO ITEM 601(a)(5) OF REGULATION S-K AND WILL BE FURNISHED SUPPLEMENTALLY TO THE SECURITIES AND EXCHANGE COMMISSION UPON REQUEST. **

** **

FIRST AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT

OF

FORUM EDGE AI LLC

a Delaware Limited Liability Company

Dated as of the Effective Date

by and between

FORUM MARKETS, INC.

and

EDGE NODE INC.

FIRST AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF FORUM EDGE AI LLC

…

EX-10.1·8-K·CIK 1690080·ACC 0001213900-26-106655·Filed Oct 05, 2026, 08:04 ET

EX-10.4

UTime Ltd

** **

NOTE: Certain identified information has been excluded from this exhibit and replaced with “[***]” because it is both (i) not material and (ii) the type of information the Company treats as private or confidential.

GRANT AGREEMENT

** **

UTIME Ltd.

** **

THIS GRANT AGREEMENT (“Grant Agreement”) is entered into as of the 17th day of September, 2026.

BETWEEN:

Utime Ltd., a company incorporated pursuant to the laws of the Cayman Islands

(the “Company”)

AND:

Li Donghong

(the “Participant”).

** **

WHEREAS:

A. The Company and the Participant previously entered into a Special Strategic Advisory Services Agreement dated September 8, 2026 (the “Services Agreement”), a copy of which is attached hereto as Exhibit A; and

B. Pursuant to the Services Agreement, the Participant agreed to provide certain strategic advisory services to the Company in exchange for compensation in the form of 600,000 shares of the Company’s Class A ordinary shares, $0.00000001 par value per share (“Ordinary Shares”); and

…

EX-10.4·6-K/A·CIK 1789299·ACC 0001493152-26-045687·Filed Oct 05, 2026, 07:33 ET

EX-10.2

UTime Ltd

NOTE: Certain identified information has been excluded from this exhibit and replaced with “[***]” because it is both (i) not material and (ii) the type of information the Company treats as private or confidential.

** **

Business Development Agreement

**EFFECTIVE DATE: **April 1, 2026

**TERM: **3 Years (April 1, 2026 — March 31, 2029)

**TOTAL AGREEMENT VALUE: **USD 3,000,000

This Business Development Agreement (hereinafter the “Agreement”) is entered into as of April 1, 2026 (the “Effective Date”), ****by and between:

**1. UTIME LIMITED, **UTime Limited, a Cayman Islands exempted company (hereinafter referred to as the “Company”);

**2. Keru JIANG **(individual, independent business development partner), with valid passport [***] (hereinafter referred to as the “BD Partner”).

The above two parties are collectively referred to as the “Parties”.

RECITALS

…

EX-10.2·6-K/A·CIK 1789299·ACC 0001493152-26-045687·Filed Oct 05, 2026, 07:33 ET

EX-10.3

UTime Ltd

** **

NOTE: Certain identified information has been excluded from this exhibit and replaced with “[***]” because it is both (i) not material and (ii) the type of information the Company treats as private or confidential.

** **

Supplemental Agreement to Business Development Agreement

** **

**Effective Date: **July 1, 2026

**Primary Agreement Reference: **Business Development Agreement dated April 1, 2026 (the “Original Agreement”) between UTIME LIMITED and Keru JIANG

** **

**Purpose: **Modification of Payment Terms - S-8 Registered Stock Settlement (Unrestricted, Legend-Free, DRS-Eligible Shares)

** **

This Supplemental Agreement (the “Supplemental Agreement”) is entered into as of July 1, 2026 (the “Supplemental Effective Date”), ****by and between:

**1. UTIME LIMITED, **UTime Limited, a Cayman Islands exempted company (hereinafter referred to as the “Company”);

** **

**2. Keru JIANG **(individual, independent business development partner), with valid passport [***] (hereinafter referred to as the “BD Partner”).

** **

…

EX-10.3·6-K/A·CIK 1789299·ACC 0001493152-26-045687·Filed Oct 05, 2026, 07:33 ET

EX-10.5

UTime Ltd

** **

Exhibit 10.5

** **

NOTE: Certain identified information has been excluded from this exhibit and replaced with “[***]” because it is both (i) not material and (ii) the type of information the Company treats as private or confidential.

** **

GRANT AGREEMENT

** **

UTIME Ltd.

** **

THIS GRANT AGREEMENT (“Grant Agreement”) is entered into as of the 17th day of September, 2026.

BETWEEN:

Utime Ltd., a company incorporated pursuant to the laws of the Cayman Islands

(the “Company”)

AND:

Keru Jiang

(the “Participant”).

** **

WHEREAS:

A. The Company and the Participant previously entered into a Business Development Agreement dated April 1, 2026 (the “Business Development Agreement”), a copy of which is attached hereto as Exhibit A; and

B. The Company and the Participant later entered into a supplemental agreement to the Business Development Agreement (the “Supplemental Agreement”), a copy of which is attached hereto as Exhibit B; and

…

EX-10.5·6-K/A·CIK 1789299·ACC 0001493152-26-045687·Filed Oct 05, 2026, 07:33 ET

EX-10.1

UTime Ltd

** **

Exhibit 10.1

** **

NOTE: Certain identified information has been excluded from this exhibit and replaced with “[***]” because it is both (i) not material and (ii) the type of information the Company treats as private or confidential.

** **

专项战略顾问服务协议

** **

SPECIAL STRATEGIC ADVISORY SERVICES AGREEMENT

** **

签署日期** / Date** 2026年 9 月 8 日 / September 8, 2026
** **
甲方** / Party A** UTIME LIMITED
** **

…

EX-10.1·6-K/A·CIK 1789299·ACC 0001493152-26-045687·Filed Oct 05, 2026, 07:33 ET

RETENSION PHARMACEUTICALS, INC. 

2026 EQUITY INCENTIVE PLAN

Effective Date: [______________]

TABLE OF CONTENTS

1. History; Existence of the Plan 1
2. Purposes of the Plan 1
3. Terminology 1

…

EX-10.4·S-1/A·CIK 2002988·ACC 0001213900-26-106636·Filed Oct 05, 2026, 07:23 ET

CONSULTING AGREEMENT

Retension Pharmaceuticals, Inc.

RETENSION PHARMACEUTICALS, INC.

CONSULTING AGREEMENT

THIS CONSULTING AGREEMENT (the “Agreement”), made effective as of January 1, 2024 (the “Effective Date”), is by and between Retension Pharmaceuticals, Inc, a Delaware corporation with offices at 902 Turkey Run Road, McLean, VA 22101 and its successors, subsidiaries and affiliates (collectively, the “Company”), and Donald Olds (“Consultant”).

WITNESSETH

WHEREAS, the Company desires to have the benefit of Consultant’s knowledge and experience, and Consultant desires to provide consulting services to the Company, all as hereinafter provided in this Agreement;

NOW, THEREFORE, in consideration of the foregoing premises and mutual agreements hereinafter set forth, the Company and Consultant hereby agree as follows:

…

EX-10.27·S-1/A·CIK 2002988·ACC 0001213900-26-106636·Filed Oct 05, 2026, 07:23 ET